Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermaroller is a German medical aesthetics and skincare company focused on microneedling devices and associated skin care products for both professional and home use. The company positions itself as an early pioneer of modern microneedling and markets a portfolio that includes the Medical Dermaroller, eDermastamp LS, XCellarisPro Twist, and topical skincare products. Its products are used across aesthetic and dermatologic applications such as anti-aging, scar reduction, stretch marks, pigmentation concerns, dry skin, and hair-loss support. Dermaroller operates internationally and states that its products are made in Germany and distributed in more than 50 countries. Historically, Dermaroller GmbH became wholly owned by mi.to.pharm GmbH in 2014, and the brand now appears to operate within the mi.to.pharm group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermaroller.